NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen FordCOO2026-11-173,668$7.46
$27.36kSell
Brian T. PowlCCO2026-11-1715,254$7.45
$113.64kSell
Mollie LeoniMed2026-11-1722,241$7.45
$165.70kSell
Troy Edward WilsonCEO;Pres2026-11-16101,119$7.42
$750.30kBuy
Teresa Brophy BairCLO2026-11-168,601$7.44
$63.99kSell
Troy Edward WilsonCEO;Pres2026-11-16101,119$7.42
$750.30kBuy
Thomas James DoyleSVP2026-11-164,697$7.44
$34.95kSell
Troy Edward WilsonCEO;Pres2026-11-16101,119$7.42
$750.30kBuy
Kathleen FordCOO2026-11-167,042$7.44
$52.39kSell
Mollie LeoniMed2026-11-1619,009$7.44
$141.43kSell

1 of 6

KURA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital Fund Qualified LP4.80%4,408,097$33.02MInsider
Troy Edward Wilson2.20%2,018,844$15.12MInsider
Pingda Ren0.84%773,982$5.80MInsider
Yi Liu0.82%749,999$5.62MInsider
Argyris Vassiliou0.41%375,000$2.81MInsider
Antonio Gualberto0.37%339,973$2.55MInsider
Heidi Henson0.27%250,000$1.87MInsider
Teresa Brophy Bair0.19%178,401$1.34MInsider
Thomas Malley0.16%149,557$1.12MInsider
Thomas James Doyle0.15%139,081$1.04MInsider

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA0.10%10.86%Net BuyingNet Buying
ANNX0.10%15.08%Net BuyingNet Buying
PRME0.07%63.02%
QUIT0.09%15.70%Net Selling
NVCT0.04%33.16%Net Buying

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 0.10% institutional shareholders, 10.86% Kura Oncology insiders, and 89.04% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 4.80% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $32.36M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.